跳至主要内容
临床试验/NCT06287138
NCT06287138
招募中
不适用

The Effect of Ciprofol on Breathing Patterns, Respiratory Drive, and Inspiratory Effort in Mechanically Ventilated Patients

Capital Medical University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年5月10日最近更新:

概览

阶段
不适用
状态
招募中
发起方
Capital Medical University
入组人数
20
试验地点
1
主要终点
Explore the effect of ciprofol on minute ventilation

概览

简要总结

Sedatives and analgesics are usually given for analgesic, anxiolytic, or sedating purposes for patients with critical illness, while they inevitably inhibit respiratory and circulatory function. Sometimes, patients receive deep sedation to induce hypoventilation or suppress spontaneous respiratory effort. The sedation level in clinical practice is usually assessed with subjective sedation scoring systems, such as the Richmond Agitation Sedation Scale (RASS). However, studies have found that sedation depth based on RASS is not a reliable marker of respiratory drive during critical illness. In recent years, researchers have proposed to monitor the effects of sedatives and analgesics on respiratory indicators and to implement lung-protective sedation, such as P0.1, Pocc, Pmus, WOB, and PTP. However, different pharmacological characteristics, different depths of sedation, and different sedation regimens among different sedatives and analgesics make a great difference in their effects on respiration. Ciprofol is an analog of propofol, with increased stereoselective effects adding to its anesthetic properties, is increasingly used in the intensive care unit, but its effects on respiration are not well understood. Therefore, this study aims to investigate the effects of ciprofol on respiratory patterns, respiratory drive, and inspiratory effort in mechanically ventilated patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient received surgery under general anesthesia and admitted into the ICU
  • The patient has been intubated and is receiving invasively mechanically ventilated with the mode of pressure support (PSV) or continuous positive airway pressure (CPAP)
  • The patient requires sedative medication targeting RASS -2 to +1 for comfort, safety and to facilitate the delivery of life support measures

排除标准

  • Age \< 18 years
  • Body mass index (BMI) \<18 or \>30 kg/m2
  • Pregnancy or lactation
  • Brain stem tumors, myasthenia gravis, or neuromuscular diseases
  • Acute severe neurological disorder and any other condition interfering with RASS assessment
  • Systolic blood pressure \< 90 mmHg after appropriate intravenous volume replacement and continuous infusions of 2 vasopressors
  • Heart rate \< 50 beats per minute or second- or third-degree heart block in the absence of a pacemaker
  • Contraindicate or allergic to any of the study medications
  • Acute hepatitis or serious hepatic dysfunction (Child-Pugh class C)
  • Chronic kidney disease with glomerular filtration rate (GFR) \< 60 ml/min/1.73m2

研究组 & 干预措施

Experimental arm

Experimental

Before the trial drug administration, included patients will receive a continuous infusion of remifentanil for analgesia, starting at 0.01 μg/kg/min and adjusting infusion rate to target a Critical-care Pain Observation Tool (CPOT) score of 0-1. The experimental drug was not to be administered until it was confirmed that the patient's baseline sedation level had reached a RASS score of ≥ -2. For sedation, the ciprofol was started at the rate of 0.3 mg/kg/h and maintained for 30 minutes. Then, the initial infusion rate was increased to 0.4, 0.5, 0.6, 0.7, and up to 0.8 mg/kg/h every 30 minutes. The infusion of ciprofol would be stopped if the RASS score ≤ -4, respiratory rate < 8 breaths/min, or Saturation of pulse oxygen (SpO2) < 90% before the maximal dose of 0.8 mg/kg/h was achieved.

干预措施: ciprofol (Drug)

结局指标

主要结局

Explore the effect of ciprofol on minute ventilation

时间窗: At baseline (before sedation with ciprofol) and 0.3 mg/kg/h ciprofol continuous infusion for 30 minutes

Change from baseline in minute ventilation (L/min) at 30 minutes after infusion of ciprofol

Explore the effect of ciprofol on tidal volume

时间窗: At baseline (before sedation with ciprofol) and 0.3 mg/kg/h ciprofol continuous infusion for 30 minutes

Change from baseline in tidal volume (ml) at 30 minutes after infusion of ciprofol

Explore the effect of ciprofol on PMI

时间窗: At baseline (before sedation with ciprofol) and 0.3 mg/kg/h ciprofol continuous infusion for 30 minutes

Change from baseline in PMI (cmH2O) at 30 minutes after infusion of ciprofol

Explore the effect of ciprofol on P0.1

时间窗: At baseline (before sedation with ciprofol) and 0.3 mg/kg/h ciprofol continuous infusion for 30 minutes

Change from baseline in P0.1 (cmH2O) at 30 minutes after infusion of ciprofol

Explore the effect of ciprofol on ΔPocc

时间窗: At baseline (before sedation with ciprofol) and 0.3 mg/kg/h ciprofol continuous infusion for 30 minutes

Change from baseline in ΔPocc (cmH2O) at 30 minutes after infusion of ciprofol

Explore the effect of ciprofol on respiratory rate

时间窗: At baseline (before sedation with ciprofol) and 0.3 mg/kg/h ciprofol continuous infusion for 30 minutes

Change from baseline in respiratory rate (breaths/min) at 30 minutes after infusion of ciprofol

次要结局

  • Explore the effect of ciprofol on respiratory rate(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.4,0.5,0.6,0.7,0.8 mg/kg/h))
  • Explore the effect of ciprofol on saturation of pulse oxygen(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.3,0.4,0.5,0.6,0.7,0.8 mg/kg/h))
  • Explore the effect of ciprofol on P0.1(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.4,0.5,0.6,0.7,0.8 mg/kg/h))
  • Explore the effect of ciprofol on PMI(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.4,0.5,0.6,0.7,0.8 mg/kg/h))
  • Explore the effect of ciprofol on ΔPocc(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.4,0.5,0.6,0.7,0.8 mg/kg/h))
  • Explore the effect of ciprofol on heart rate(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.3,0.4,0.5,0.6,0.7,0.8 mg/kg/h))
  • Explore the effect of ciprofol on mean arterial pressure(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.3,0.4,0.5,0.6,0.7,0.8 mg/kg/h))
  • Explore the effect of ciprofol on end-tidal carbon dioxide pressure(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.3,0.4,0.5,0.6,0.7,0.8 mg/kg/h))
  • Explore the effect of ciprofol on tidal volume(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.4,0.5,0.6,0.7,0.8 mg/kg/h))
  • Explore the effect of ciprofol on minute ventilation(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.4,0.5,0.6,0.7,0.8 mg/kg/h))
  • Explore the effect of ciprofol on diastolic blood pressure(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.3,0.4,0.5,0.6,0.7,0.8 mg/kg/h))
  • Explore the effect of ciprofol on systolic blood pressure(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.3,0.4,0.5,0.6,0.7,0.8 mg/kg/h))
  • Explore the effect of ciprofol on RASS score(At baseline (before sedation with ciprofol) and 30 minutes following each infusion rate adjustment (0.3,0.4,0.5,0.6,0.7,0.8 mg/kg/h))

研究者

发起方
Capital Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jian-Xin Zhou

Professor

Capital Medical University

研究点 (1)

Loading locations...

相似试验